Want to create an interactive transcript for this episode?
Podcast: The IBJ Podcast with Mason King
Episode: Lilly in middle of big battle over future of drug prices for seniors
Description: The health care industry in America is on the precipice of its biggest change at least since the passage of Obamacare 13 years ago. Passed last summer, the Inflation Reduction Act has given Medicare the green light to negotiate the prices of some drugs for its 60 million-some recipients. The program is expected to save patients many billions of dollars while significantly shrinking revenue for some pharmaceutical firms. Indianapolis-based Eli Lilly and Co. is intensely concerned about this development. Two of its most popular medicines are expected to be among the first 40 drugs subject to negotiations.
Lilly CEO David...